Brazil negotiates with the U.S. for possible purchase of COVID-19 vaccine

Brazil negotiates with the U.S. for possible purchase of COVID-19 vaccine

Brazilian Foreign Ministry says talks with Washington on possible exports of surplus vaccine have been ongoing since March 13

The Brazilian government has been in talks with Washington, D.C., since March 13 about the possible import of surplus COVID-19 vaccine, the Brazilian Foreign Ministry said Saturday.

According to the ministry’s tweet, the foreign ministry and the Brazilian embassy in Washington, D.C., are working with the health ministry to negotiate with the U.S. administration about a possible purchase of the vaccine.

The White House on Friday announced plans to transfer to Canada and Mexico 4 million doses of the AstraZeneca vaccine, which has already been produced in the United States. According to an administration official, the White House has no plans to transfer this batch of vaccines to other countries.

Brazil is facing the world’s second-worst coronavirus outbreak after the United States. The situation has been exacerbated by a new wave of infections that has brought the country’s health care system to the brink of collapse. Brazil’s Ministry of Health reported Friday that in the past 24 hours a record of more than 90,000 new cases of coronavirus infections in a 24-hour period had been broken, as well as the sad record of deaths, the second-highest since the pandemic began.

ALSO READ:  Pfizer and BioNTech ready to vaccinate 12-year-olds

The federal government is in no hurry to vaccinate, with local governments having to suspend vaccinations in various regions due to lack of medication.